PECAM1 and breast cancer: Besides its effects on the survival of tumor cells, IL-23 induced the expression of the proliferative marker Ki67 and endothelial marker CD31, promoting tumor cell proliferation, mammary tumor growth and pulmonary metastasis in mouse models of breast cancer [105].